Thursday , 21 November 2024
Home Tasuku Honjo

Tasuku Honjo

PD-1 Antibody Targeting Immune Checkpoint Inhibition
Healthcare

Cancer Treatment’s New Hope: Checkpoint Inhibitors

Two decades ago, patients with aggressive cancers faced grim prognoses, as treatment options were limited. However, a paradigm shift occurred with the introduction...